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The First Reported Case of Aerococcus
Bacteremia in a Patient with HIV Infection
To the Editor:         We report the first case of
Aerococcus viridans bacteremia in a patient with
HIV infection. Two species in the genus
Aerococcus have been implicated as rare
pathogens in humans. A. urinae causes urinary
tract infections; the other species, A. viridans, a
gram-positive coccus considered a contaminant
in cultures, has been associated with human
infections that included bacteremia (1,2), septic
arthritis (3), and infectious endocarditis (4,5).
Widely distributed in the environment, the
organism has been recovered from dust,
vegetables, and crustaceans (6) and was isolated
from different areas in a hospital (recovery room,
intensive care unit, delivery room, treatment
room, premature nursery) and from numerous
objects (7).
We describe the first case of A. viridans
bacteremia in a patient with HIV. A 34-year-old
man without notable medical history sought
medical attention after several weeks of
epigastric midabdominal pain associated with a
15-lb weight loss; the pain did not respond to
antacid medications. The patient said that he did
not have fever, chills, night sweats, or history of
transfusions and did not use alcohol, tobacco, or
drugs. He had engaged in homosexual activity 2
to 3 years earlier.
Physical examination showed moderate
cachexia and low-grade fever (38.8ºC)         associated
with tachycardia, but the heart and lung
examination was otherwise normal. The abdo-
men was soft, flat, and tender to palpation in the
midabdominal epigastric area, without
hepatosplenomegaly, guarding, or rebound
tenderness. No other abnormalities were
identified. The patient was admitted to the
hospital, and the initial set of routine blood
cultures (Bactec 9240 instrument, Becton
Dickinson, Sparks, MD) showed no growth. On
hospital day 2, he began to have severe rigors,
along with persistent fever. A second set of blood
cultures drawn at that time grew paired gram-
positive cocci in less than 24 hours. The patient
was empirically started on penicillin G, and
cefotaxime was added shortly thereafter because
of the possibility of intermediately resistant
pneumococcus. The rigors responded to antibi-
otic treatment, and a third set of blood cultures
showed no growth. The negative blood cultures
before and after appropriate antimicrobial
therapy and the short time to detection (which
suggests a large initial inoculum) led us to
believe that the organism in this case was a true
pathogen and not a contaminant.
The patient’s work-up included a normal
abdominal  computer tomography; abdominal
ultrasound showed nonobstructing cholelithiasis.
Laboratory tests demonstrated anemia of
chronic disease diagnosed by a hematocrit of 25%
associated with a low reticulocyte production
index, high serum ferritin, and an elevated
erythrocyte sedimentation rate (91 mm/hr), with
polyclonal hypergammaglobulinemia and
hypoalbuminemia on serum protein
electrophoresis. Stool samples were negative for
occult blood, and serologic tests showed no
Helicobacter pylori antibodies. The patient’s
total lymphocyte count was 300 cells/µl, HIV
serologic testing by enzyme-linked
immunosorbent assay and Western blot was
positive, and flow cytometry revealed an
absolute CD4+ T-lymphocyte count of 19 cells/µl,
with an HIV-1 retroviral titer of 280,000 by
polymerase chain reaction. Gallium scanning
was negative for Pneumocystis carinii pneumonia
and gastrointestinal lymphoma. A follow-up
endoscopy showed esophageal ulcers, with
disruption of the mucosal barrier. Blood cultures
were negative for cytomegalovirus or
mycobacteria, but the aerobic isolate initially
reported as paired gram-positive cocci was later
identified as A. viridans.
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the basis of the following characteristics:
catalase negativity, a-hemolytic gram-positive
cocci forming pairs and tetrads (not chains) in
broth culture; growth in the presence of 40% bile
and 6.5% NaCl and ability to hydrolyze esculin;
pyrrolidony l-aminopeptidase positivity, leucine-
aminopeptidase negativity; and production of
acid from trehalose, sucrose, maltose, and
lactose but not from sorbitol.
Susceptibility testing by the agar dilution
method showed that the isolate was susceptible
to penicillin-G (MIC = 0.12 µg/ml) and vancomycin
(MIC = 0.25 µg/ml). On the basis of this case and
previous reports (1,2), we believe that A. viridans
is a potential pathogen that can cause serious
infections in immunocompromised patients. The
presumed route of infection in this patient was
esophageal ulcers. Clinical microbiologists should
pay close attention to a-hemolytic, catalase-
negative streptococci recovered from sterile body
sites that form tetrads rather than chains on
Gram stain.
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Proficiency in Detecting Vancomycin
Resistance in Enterococci among Clinical
Laboratories in Santiago, Chile
To the Editor:         Vancomycin-resistant enterococci
(VRE) can be difficult to detect because of
limitations in the susceptibility testing methods
commonly used in clinical laboratories. Although
VRE have not been reported in Chile, clinical
isolates have been reported in Argentina (1) and
Brazil (2). It is important to detect vancomycin
resistance as early as possible, so infection
control preventive measures can be instituted
when they have their greatest impact. The
microbiology laboratory is the first line of
defense against VRE, as it plays a critical role in
its recognition. In Chile, most laboratories follow
the National Committee for Clinical Laboratory
Standards recommendations for antimicrobial
susceptibility testing and use disk-diffusion
methods (3); however, these methods have
limitations in detecting low levels of resistance to
vancomycin in enterococci.
We evaluated the ability of referral
microbiology laboratories in Chile to detect
vancomycin resistance in five Enteroccocus spp.
isolates with different susceptibility patterns for
vancomycin, penicillin, and ampicillin. Of six
referral laboratories that agreed to participate,
four used the disk-diffusion method to evaluate
antimicrobial susceptibility. Two used an agar
dilution minimum inhibitory concentration (MIC)
method, one as the only susceptibility testing
method and the other in addition to disk diffusion.
The participants correctly evaluated vancomycin
susceptibility in 17 (57%) of 30 isolates.
The accuracy of detecting vancomycin resis-
tance varied according to the level of resistance.
Isolate 1, which had a high level of resistance
(Van A phenotype, MIC 256 µg/ml), was evaluated
correctly in 5 (83%) of 6 laboratories. Isolate 2,
with a lower level of resistance (Van B, MIC
64 µg/ml), was evaluated correctly in 4 (67%) of 6
laboratories. Isolates 3 and 4, both with
intermediate resistance (Van B, MIC 16-32 µg/ml,
and Van C, MIC 8 µg/ml, respectively), were
evaluated correctly by one laboratory each.
Isolate 5 (vancomycin susceptible) was evaluated
correctly by all laboratories. Susceptibility to
penicillin and ampicillin was correctly identified
in 53 (96.4%) of 55 isolates. Although laboratories